Hudson Seminar Series | Professor Andrew Wilks
Professor Andrew Wilks (FTSE, FAHMS) Fellow of the Australian Academy of Technology and Engineering (ATSE) and of the Australian Academy of Health and Medical Sciences (AAHMS) will be presenting a seminar titled ‘Twenty five years on the dark side: and what happens now …’.
Professor Andrew Wilks is a serial entrepreneur with twenty five years on the “dark side”, following a successful academic career as a cancer researcher at the Ludwig Institute for Cancer Research. His laboratory focused on the intracellular processes that underpinned the development of cancer. He discovered and named (and, indeed, patented) key cell signalling molecules, including the JAK family of kinases, and went on to found Cytopia in 1997. At Cytopia, he developed a number of new therapeutics. Since then he has founded or co-founded eleven companies that
undertake self-funded drug discovery or provide drug discovery services to the global drug discovery sector. In particular, he was co-founder (with Dr Xian Bu) of SYNthesis med chem, a global contract chemistry group and The Pharm (aka SYNthesis Research), a “venture-discovery” company that funds and manages drug discovery collaborations generated from academia.
Andrew holds an Adjunct/Honorary Professorship in the Department of Medicine, Nursing and Health Sciences at Monash University, and is an Honorary Enterprise Professor in the Faculty of Medicine, Dentistry and Health Sciences at the University of Melbourne. He is a WEHI Fellow. He is an elected Fellow of the Australian Academy of Technology and Engineering (ATSE) and of the Australian Academy of Health and Medical Sciences (AAHMS).